Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-011079
Filing Date
2022-03-18
Accepted
2022-03-18 16:31:43
Documents
6
Effectiveness Date
2022-03-18

Document Format Files

Seq Description Document Type Size
1 S-8 onct-s8.htm S-8 235706
2 EX-5.1 onct-ex51_7.htm EX-5.1 24694
3 EX-23.1 onct-ex231_6.htm EX-23.1 3638
4 EX-FILING FEES onct-exfilingfees_134.htm EX-FILING FEES 25758
5 GRAPHIC gtgedrx2bf31000002.jpg GRAPHIC 58309
6 GRAPHIC gtgedrx2bf31000001.jpg GRAPHIC 8497
  Complete submission text file 0001564590-22-011079.txt   383199
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263703 | Film No.: 22752979
SIC: 2834 Pharmaceutical Preparations